费城儿童医院早产儿视网膜病变(CHOP ROP)模型的验证
本研究为G-ROP研究的二次分析,在美国和加拿大30家医院纳入7483名有已知ROP结局的早产儿,验证CHOP ROP模型预测需治疗ROP的敏感性。原模型正确预测459例1型ROP中的452例(敏感性98.5%,95%CI 96.9%-99.3%),仅高危儿接受检查可使需检查婴儿数减少34.3%。结论认为该模型敏感性高但非100%,可能更适合用于减少检查频率。
要点
- CHOP ROP模型对1型ROP的敏感性为98.5%(95%CI 96.9%-99.3%),正确预测452/459例。
- 仅高危儿接受检查可使需检查婴儿数减少34.3%;降低切点至敏感性100%时仅6.8%婴儿无需检查。
- 低危儿在矫正胎龄37周检查、仅异常者随访,可捕捉全部1型ROP,胎龄>27周者检查次数减少28.4%。
核心结论
- CHOP ROP模型表现出高但非100%的敏感性,可能更适合用于减少检查频率。
- 该模型可能可靠地用于指导修改后的ROP筛查计划并减少检查次数。
研究设计与样本
- 本研究为对Postnatal Growth and Retinopathy of Prematurity(G-ROP)研究数据的二次分析。
- 研究设置于美国和中国加拿大30家医院,时间为2006年1月1日至2012年6月30日,分析日期为2015年9月28日至10月5日。
- 参与者为有已知ROP结局的早产儿,共纳入7483名。
主要发现
- 参与者中位出生体重为1070 g(范围310-3000 g),中位胎龄为28周(范围22-35周)。
- 3575名(47.8%)为女性;种族/族裔为3615名白人(48.3%)、2310名黑人(30.9%)、233名亚洲人(3.1%)、93名太平洋岛民(1.2%)、40名美洲印第安人/阿拉斯加原住民(0.5%)。
- 原CHOP ROP模型正确预测459例发生1型ROP婴儿中的452例,敏感性98.5%(95%CI 96.9%-99.3%),若仅高危婴儿接受检查可使需检查婴儿数减少34.3%。
- 将切点降低至捕捉所有1型ROP病例(敏感性100%,95%CI 99.2%-100%)时,仅6.8%婴儿无需检查。
- 若低危婴儿在矫正胎龄37周接受检查且仅在检查时存在ROP才随访,则可捕捉所有1型ROP病例,胎龄超过27周的婴儿检查次数减少28.4%。
关键数值与推荐
- CHOP ROP模型使用出生体重、出生胎龄和体重增长率预测严重ROP风险,风险高于切点水平(高危)时需检查,低危婴儿不检查。
- 二次分析中低危婴儿接受更少检查而非不检查。
临床怎么用
- 原文结论认为该模型可能可靠地用于指导修改后的ROP筛查计划并减少检查次数。
局限性
- CHOP ROP模型敏感性高但非100%。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) model uses birth weight (BW), gestational age at birth (GA), and weight gain rate to predict the risk of severe retinopathy of prematurity (ROP). In a model development study, it predicted all infants requiring treatment, while greatly reducing the number of examinations compared with current screening guidelines. OBJECTIVE: To validate the CHOP ROP model in a multicenter cohort that is large enough to obtain a precise estimate of the model's sensitivity for treatment-requiring ROP. DESIGN, SETTING, AND PARTICIPANTS: This investigation was a secondary analysis of data from the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. The setting was 30 hospitals in the United States and Canada between January 1, 2006, and June 30, 2012. The dates of analysis were September 28 to October 5, 2015. Participants were premature infants at risk for ROP with a known ROP outcome. MAIN OUTCOMES AND MEASURES: Sensitivity for Early Treatment of Retinopathy of Prematurity type 1 ROP and potential reduction in the number of infants requiring examinations. In the primary analysis, the CHOP ROP model was applied weekly to predict the risk of ROP. If the risk was above a cut-point level (high risk), examinations were indicated, while low-risk infants received no examinations. In a secondary analysis, low-risk infants received fewer examinations rather than no examinations. RESULTS: Participants included 7483 premature infants at risk for ROP with a known ROP outcome. Their median BW was 1070 g (range, 310-3000 g), and their median GA was 28 weeks (range, 22-35 weeks). Among them, 3575 (47.8%) were female, and their race/ethnicity was 3615 white (48.3%), 2310 black (30.9%), 233 Asian (3.1%), 93 Pacific Islander (1.2%), and 40 American Indian/Alaskan native (0.5%). The original CHOP ROP model correctly predicted 452 of 459 infants who developed type 1 ROP (sensitivity, 98.5%; 95% CI, 96.9%-99.3%), reducing the number of infants requiring examinations by 34.3% if only high-risk infants received examinations. Lowering the cut point to capture all type 1 ROP cases (sensitivity, 100%; 95% CI, 99.2%-100%) resulted in only 6.8% of infants not requiring examinations. However, if low-risk infants were examined at 37 weeks' postmenstrual age and followed up only if ROP was present at that examination, all type 1 ROP cases would be captured, and the number of examinations performed among infants with GA exceeding 27 weeks would be reduced by 28.4%. CONCLUSION AND RELEVANCE: The CHOP ROP model demonstrated high but not 100% sensitivity and may be better used to reduce examination frequency. The model might be used reliably to guide a modified ROP screening schedule and decrease the number of examinations performed.
引用
- Binenbaum G, Ying GS, Tomlinson LA, et al. Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model. JAMA Ophthalmol. 2017. PMID: 28715553. doi:10.1001/jamaophthalmol.2017.2295
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。